In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

Axsome Therapeutics shares were up 14% in premarket trading after reaching a settlement with Teva Pharmaceuticals. Shares were trading around $120.01. The stock is up 8.3% over the last year.

Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.

Just don’t ask him which division the Rams are in or what their logo looks like. During his stroll through radio row at the Super Bowl on Wednesday, Nacua was asked by Sports Illustrated to draw ...

Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 on Wednesday. The company lost over 20% in the preceding six sessions.

That’s because the supermarket is removing its iconic logo from Bags For Life, and replacing it with some other five-letter words. Shoppers might notice that instead of the word ‘Tesco ...

Football fans think the Super Bowl logo offers a telling prediction. For the past several NFL seasons, followers of the sport have dialed in on a theory that states the Super Bowl art accurately ...